Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ICLR | ICON plc | 1.08% | 253.09 | 2.8% | $146.45m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.02% | 23.83 | 14.1% | $140.22m | |
| HZNP | Horizon Therapeutics Plc | 0.94% | 87.41 | 5.4% | $126.34m | |
| CTLT | Catalent, Inc. | -2.27% | 98.07 | 2.0% | $114.64m | |
| BHC | Bausch Health Cos., Inc. | -2.02% | 23.83 | 0.0% | $104.73m | |
| ZGNX | Zogenix, Inc. | 0.00% | 25.93 | 7.4% | $101.43m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.51% | 133.02 | 2.1% | $91.93m | |
| SAVA | Cassava Sciences, Inc. | -1.42% | 39.45 | 0.0% | $88.72m | |
| UTHR | United Therapeutics Corp. | -0.58% | 198.57 | 13.9% | $84.10m | |
| ARGX | argenx SE | -0.83% | 258.11 | 0.0% | $53.54m | |
| PRGO | Perrigo Co. Plc | -1.53% | 38.02 | 6.9% | $50.46m | |
| PCRX | Pacira Biosciences, Inc. | -0.45% | 61.56 | 9.8% | $29.97m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | -2.60% | 10.85 | 9.5% | $23.90m | |
| SAGE | SAGE Therapeutics, Inc. | -3.97% | 37.75 | 7.6% | $18.18m | |
| TBPH | Theravance Biopharma, Inc. | 1.14% | 8.85 | 7.4% | $17.48m |
Company Profile
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.